Free Trial

HilleVax (HLVX) Competitors

HilleVax logo
$2.09 -0.01 (-0.48%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$2.06 -0.03 (-1.48%)
As of 07/11/2025 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HLVX vs. RZLT, PRME, ERAS, TECX, SLDB, ITOS, ETON, ALT, CMPX, and CYRX

Should you be buying HilleVax stock or one of its competitors? The main competitors of HilleVax include Rezolute (RZLT), Prime Medicine (PRME), Erasca (ERAS), Tectonic Therapeutic (TECX), Solid Biosciences (SLDB), iTeos Therapeutics (ITOS), Eton Pharmaceuticals (ETON), Altimmune (ALT), Compass Therapeutics (CMPX), and CryoPort (CYRX). These companies are all part of the "pharmaceutical products" industry.

HilleVax vs. Its Competitors

Rezolute (NASDAQ:RZLT) and HilleVax (NASDAQ:HLVX) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, media sentiment, valuation and analyst recommendations.

Rezolute currently has a consensus price target of $11.83, suggesting a potential upside of 124.97%. HilleVax has a consensus price target of $2.00, suggesting a potential downside of 4.31%. Given Rezolute's stronger consensus rating and higher probable upside, equities research analysts clearly believe Rezolute is more favorable than HilleVax.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rezolute
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
3.14
HilleVax
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Rezolute is trading at a lower price-to-earnings ratio than HilleVax, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RezoluteN/AN/A-$68.46M-$1.15-4.57
HilleVaxN/AN/A-$147.27M-$2.15-0.97

HilleVax's return on equity of -51.86% beat Rezolute's return on equity.

Company Net Margins Return on Equity Return on Assets
RezoluteN/A -70.09% -63.08%
HilleVax N/A -51.86%-41.45%

83.0% of Rezolute shares are owned by institutional investors. Comparatively, 86.4% of HilleVax shares are owned by institutional investors. 18.4% of Rezolute shares are owned by company insiders. Comparatively, 24.9% of HilleVax shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Rezolute had 2 more articles in the media than HilleVax. MarketBeat recorded 5 mentions for Rezolute and 3 mentions for HilleVax. HilleVax's average media sentiment score of 1.46 beat Rezolute's score of 0.72 indicating that HilleVax is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Rezolute
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
HilleVax
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Rezolute has a beta of 1.03, indicating that its stock price is 3% more volatile than the S&P 500. Comparatively, HilleVax has a beta of 0.76, indicating that its stock price is 24% less volatile than the S&P 500.

Summary

Rezolute beats HilleVax on 8 of the 14 factors compared between the two stocks.

Get HilleVax News Delivered to You Automatically

Sign up to receive the latest news and ratings for HLVX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HLVX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HLVX vs. The Competition

MetricHilleVaxMED IndustryMedical SectorNASDAQ Exchange
Market Cap$105.30M$2.97B$5.62B$9.10B
Dividend YieldN/A2.39%5.24%4.00%
P/E Ratio-0.9720.5828.0520.27
Price / SalesN/A292.05429.5999.27
Price / CashN/A42.8637.4658.16
Price / Book0.677.638.055.49
Net Income-$147.27M-$55.05M$3.18B$250.45M
7 Day Performance1.70%8.43%3.60%4.77%
1 Month Performance8.85%5.42%4.03%7.66%
1 Year Performance19.43%2.03%29.49%16.39%

HilleVax Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HLVX
HilleVax
2.1123 of 5 stars
$2.09
-0.5%
$2.00
-4.3%
+25.1%$105.30MN/A-0.9720News Coverage
Positive News
RZLT
Rezolute
2.5905 of 5 stars
$4.98
+3.3%
$11.83
+137.6%
+22.9%$412.20MN/A-4.3340News Coverage
High Trading Volume
PRME
Prime Medicine
3.9289 of 5 stars
$3.80
+22.2%
$10.08
+165.4%
-27.5%$408.32M$3.85M-1.85234Positive News
High Trading Volume
ERAS
Erasca
3.2141 of 5 stars
$1.42
-1.4%
$4.57
+221.9%
-48.4%$407.93MN/A-2.29120News Coverage
TECX
Tectonic Therapeutic
2.6203 of 5 stars
$20.78
-2.6%
$83.60
+302.3%
+37.7%$398.47MN/A-2.84120Gap Down
SLDB
Solid Biosciences
3.1534 of 5 stars
$4.91
-2.4%
$15.10
+207.5%
-35.8%$389.90M$8.09M-1.64100News Coverage
Gap Down
ITOS
iTeos Therapeutics
3.3166 of 5 stars
$10.07
-1.1%
$15.86
+57.5%
-36.5%$389.63M$35M-3.3190
ETON
Eton Pharmaceuticals
1.9777 of 5 stars
$14.39
-0.4%
$29.67
+106.2%
+322.4%$387.51M$39.01M-79.9420
ALT
Altimmune
2.2384 of 5 stars
$4.43
-6.9%
$19.00
+328.9%
-46.1%$386.07M$20K-3.5250News Coverage
Analyst Forecast
Gap Down
CMPX
Compass Therapeutics
3.0139 of 5 stars
$2.64
-5.0%
$12.67
+379.8%
+159.6%$384.43M$850K-6.4420News Coverage
Positive News
CYRX
CryoPort
1.8271 of 5 stars
$7.29
-4.8%
$10.88
+49.2%
+7.4%$384.05M$228.38M-3.121,186

Related Companies and Tools


This page (NASDAQ:HLVX) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners